A Randomized Placebo-Controlled Pilot Trial of Omega-3 Fatty Acids and Alpha Lipoic Acid in Alzheimer’s Disease
暂无分享,去创建一个
Dana Waichunas | Hiroko H. Dodge | Joseph Quinn | Jeffrey Kaye | William Woodward | Dennis Bourdette | Lisa Silbert | T. Montine | J. Kaye | H. Dodge | J. Quinn | W. Woodward | L. Silbert | D. Bourdette | D. Waichunas | Lynne Shinto | L. Shinto | S. Baldauf-Wagner | L. Bumgarner | Thomas Montine | Sara Baldauf-Wagner | Lauren Bumgarner | Sara Baldauf-Wagner | Dana Waichunas
[1] C. Cotman,et al. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. , 2012, Archives of neurology.
[2] R. Hui,et al. Effects of n-3 PUFA supplementation on plasma soluble adhesion molecules: a meta-analysis of randomized controlled trials. , 2012, The American journal of clinical nutrition.
[3] D. Kelley,et al. Similarities and differences between the effects of EPA and DHA on markers of atherosclerosis in human subjects* , 2012, Proceedings of the Nutrition Society.
[4] J. Kaye,et al. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging , 2011, Neurology.
[5] D. Bourdette,et al. Lipoic acid stimulates cAMP production via G protein-coupled receptor-dependent and -independent mechanisms. , 2011, The Journal of nutritional biochemistry.
[6] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[7] Michael Weiner,et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. , 2010, JAMA.
[8] D. Bourdette,et al. Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling , 2010, PloS one.
[9] G. Cole,et al. DHA may prevent age-related dementia. , 2010, The Journal of nutrition.
[10] G. Jicha,et al. Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease , 2010, Clinical interventions in aging.
[11] D. Bourdette,et al. Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters , 2010, Multiple sclerosis.
[12] R. Moreau,et al. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. , 2009, Biochimica et biophysica acta.
[13] G. Kolovou,et al. Lipids in Health and Disease , 2009 .
[14] M. Zdanowicz,et al. Therapeutic potential of n-3 polyunsaturated fatty acids in disease. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[15] T. Billiar,et al. The Plasma Pharmacokinetics of R-(+)-Lipoic Acid cited in the following articles (listed chronologically); Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM. Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic , 2009 .
[16] J. Quinn,et al. Nutritional biomarkers in Alzheimer's disease: the association between carotenoids, n-3 fatty acids, and dementia severity. , 2008, Journal of Alzheimer's disease : JAD.
[17] P. Barberger-Gateau,et al. Dietary patterns and risk of dementia , 2007, Neurology.
[18] T. Montine,et al. Chronic dietary α-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice , 2007, Neurobiology of Aging.
[19] G. Münch,et al. Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis. , 2007, Journal of neural transmission. Supplementum.
[20] G. Münch,et al. α-Lipoic acid as a new treatment option for Alzheimer’s disease — a 48 months follow-up analysis , 2007 .
[21] T. Montine,et al. Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. , 2007, Neurobiology of aging.
[22] Lars-Olof Wahlund,et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. , 2006, Archives of neurology.
[23] P. Kamenova. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. , 2006, Hormones.
[24] Xin-guo Jiang,et al. Quantification of lipoic acid in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[25] A. Larsson,et al. Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men. , 2005, Atherosclerosis.
[26] D. Bennett,et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. , 2003, Archives of neurology.
[27] M. Grundman,et al. Antioxidant strategies for Alzheimer's disease , 2002, Proceedings of the Nutrition Society.
[28] D. Hughes,et al. Alpha-lipoic acid modulates NF-κB activity in human monocytic cells by direct interaction with DNA , 2002, Experimental Gerontology.
[29] S. Basu,et al. F2-isoprostane and prostaglandin F2αmetabolite excretion rate and day to day variation in healthy humans , 2001 .
[30] S. Basu,et al. F(2)-isoprostane and prostaglandin F(2 alpha)metabolite excretion rate and day to day variation in healthy humans. , 2001, Prostaglandins, leukotrienes, and essential fatty acids.
[31] T. Mori,et al. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. , 1999, Analytical biochemistry.
[32] J. Trojanowski,et al. Increased F2‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] A. Hofman,et al. Dietary fat intake and the risk of incident dementia in the Rotterdam study , 1997, Annals of neurology.
[34] A Bast,et al. The pharmacology of the antioxidant lipoic acid. , 1997, General pharmacology.
[35] M. Sano,et al. An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease , 1997, Alzheimer disease and associated disorders.
[36] C. Sen,et al. Alpha-lipoic acid: a metabolic antioxidant and potential redox modulator of transcription. , 1997, Advances in pharmacology.
[37] G. Anderson,et al. Placental transfer of essential fatty acids in humans: venous-arterial difference for docosahexaenoic acid in fetal umbilical erythrocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[38] K. Davis,et al. A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.
[39] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.